Veeva Revenue Jumps 17% in Fiscal Q2
Veeva Systems (NYSE:VEEV), a leading provider of cloud software and data solutions for the life sciences industry, delivered its fiscal second quarter 2026 earnings on Aug. 27, 2025. The standout headline was GAAP revenue of $789.1 million, up 17.0% from the previous year, exceeding the analysts' estimate of $768.45 million. Non-GAAP earnings per share reached $1.99, beating consensus, and Non-GAAP earnings per share grew 22.8% year over year. Profit margins (non-GAAP) improved in Q2 FY2026, with non-GAAP operating margin hitting 44.7%. Performance this quarter reflected robust customer adoption and strong results across both commercial and research and development product lines.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2026 earnings report.
Veeva Systems provides specialized cloud and data platforms for life sciences firms. Its core focus is helping pharmaceutical, biotechnology, and medical device companies manage research data, regulatory needs, marketing, and patient relationships -- all within a secure, compliant environment. By building software specifically for the unique regulatory and operational challenges these companies face, Veeva has become a key technology partner to firms across the healthcare sector.
Source Fool.com
